Table 1.
Demographics and baseline characteristics of patients.
| Characteristic | Value |
|---|---|
| Age (years), mean±SD | 48.2±11.5 |
| Gender | |
| Postmenopausal women | 15 (50%) |
| Perimenopausal women | 15 (50%) |
| Duration (months), mean±SD | 81.3±68.1 |
| Macroscopic characteristics of lesions atrophy | 30 |
| Hyperkeratosis | 30 (100%) |
| Depigmentation | 30 (100%) |
| Sclerosis | 19 (63%) |
| Previous treatment | 23 (77%) |
| Topical corticosteroids | 22 (73%) |
| Topical calcineurin inhibitors | 0 (0%) |
| Estrogens | 0 (0%) |
| Local injection | 0 (0%) |
| UVA1 | 0 (0%) |
| Others | 1 (3%) |